TELEFLEX INC (TFX) Fundamental Analysis & Valuation

NYSE:TFX • US8793691069

117.12 USD
-2.06 (-1.73%)
Last: Mar 5, 2026, 01:42 PM

This TFX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

4

Overall TFX gets a fundamental rating of 4 out of 10. We evaluated TFX against 184 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and the financial health of TFX get a neutral evaluation. Nothing too spectacular is happening here. TFX has a bad growth rate and is valued cheaply. These ratings would make TFX suitable for value investing!


Dividend Valuation Growth Profitability Health

5

1. TFX Profitability Analysis

1.1 Basic Checks

  • TFX had positive earnings in the past year.
  • In the past year TFX had a positive cash flow from operations.
  • TFX had positive earnings in 4 of the past 5 years.
  • Each year in the past 5 years TFX had a positive operating cash flow.
TFX Yearly Net Income VS EBIT VS OCF VS FCFTFX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M

1.2 Ratios

  • TFX's Return On Assets of -13.04% is in line compared to the rest of the industry. TFX outperforms 57.61% of its industry peers.
  • TFX has a Return On Equity (-28.98%) which is in line with its industry peers.
  • With a decent Return On Invested Capital value of 5.83%, TFX is doing good in the industry, outperforming 78.80% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for TFX is significantly below the industry average of 8.90%.
  • The 3 year average ROIC (3.28%) for TFX is below the current ROIC(5.83%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -13.04%
ROE -28.98%
ROIC 5.83%
ROA(3y)-2.44%
ROA(5y)1%
ROE(3y)-6.44%
ROE(5y)0.53%
ROIC(3y)3.28%
ROIC(5y)4.67%
TFX Yearly ROA, ROE, ROICTFX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 -20

1.3 Margins

  • The Operating Margin of TFX (15.41%) is better than 83.70% of its industry peers.
  • TFX's Operating Margin has declined in the last couple of years.
  • TFX has a Gross Margin of 53.30%. This is comparable to the rest of the industry: TFX outperforms 49.46% of its industry peers.
  • In the last couple of years the Gross Margin of TFX has remained more or less at the same level.
Industry RankSector Rank
OM 15.41%
PM (TTM) N/A
GM 53.3%
OM growth 3Y-11.31%
OM growth 5Y-8.15%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.83%
GM growth 5Y1.5%
TFX Yearly Profit, Operating, Gross MarginsTFX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 60

5

2. TFX Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so TFX is destroying value.
  • TFX has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for TFX has been reduced compared to 5 years ago.
  • The debt/assets ratio for TFX is higher compared to a year ago.
TFX Yearly Shares OutstandingTFX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
TFX Yearly Total Debt VS Total AssetsTFX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

  • An Altman-Z score of 2.31 indicates that TFX is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • TFX's Altman-Z score of 2.31 is fine compared to the rest of the industry. TFX outperforms 64.13% of its industry peers.
  • TFX has a debt to FCF ratio of 10.76. This is a negative value and a sign of low solvency as TFX would need 10.76 years to pay back of all of its debts.
  • With a decent Debt to FCF ratio value of 10.76, TFX is doing good in the industry, outperforming 72.28% of the companies in the same industry.
  • TFX has a Debt/Equity ratio of 0.81. This is a neutral value indicating TFX is somewhat dependend on debt financing.
  • TFX's Debt to Equity ratio of 0.81 is on the low side compared to the rest of the industry. TFX is outperformed by 71.74% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.81
Debt/FCF 10.76
Altman-Z 2.31
ROIC/WACC0.61
WACC9.62%
TFX Yearly LT Debt VS Equity VS FCFTFX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.3 Liquidity

  • TFX has a Current Ratio of 2.54. This indicates that TFX is financially healthy and has no problem in meeting its short term obligations.
  • With a Current ratio value of 2.54, TFX perfoms like the industry average, outperforming 52.72% of the companies in the same industry.
  • TFX has a Quick Ratio of 2.01. This indicates that TFX is financially healthy and has no problem in meeting its short term obligations.
  • TFX has a Quick ratio (2.01) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.54
Quick Ratio 2.01
TFX Yearly Current Assets VS Current LiabilitesTFX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

1

3. TFX Growth Analysis

3.1 Past

  • TFX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -12.63%.
  • The Earnings Per Share has been growing slightly by 2.78% on average over the past years.
  • The Revenue has decreased by -2.75% in the past year.
  • TFX shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -4.72% yearly.
EPS 1Y (TTM)-12.63%
EPS 3Y-2.14%
EPS 5Y2.78%
EPS Q2Q%-50.39%
Revenue 1Y (TTM)-2.75%
Revenue growth 3Y-10.62%
Revenue growth 5Y-4.72%
Sales Q2Q%-28.47%

3.2 Future

  • Based on estimates for the next years, TFX will show a decrease in Earnings Per Share. The EPS will decrease by -1.79% on average per year.
  • The Revenue is expected to decrease by -3.02% on average over the next years.
EPS Next Y-6.4%
EPS Next 2Y0.56%
EPS Next 3Y-4.92%
EPS Next 5Y-1.79%
Revenue Next Year-12.37%
Revenue Next 2Y-4.6%
Revenue Next 3Y-8.6%
Revenue Next 5Y-3.02%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
TFX Yearly Revenue VS EstimatesTFX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 1B 2B 3B 4B
TFX Yearly EPS VS EstimatesTFX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 5 10 15

7

4. TFX Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 9.57, which indicates a very decent valuation of TFX.
  • 95.11% of the companies in the same industry are more expensive than TFX, based on the Price/Earnings ratio.
  • TFX is valuated cheaply when we compare the Price/Earnings ratio to 27.03, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 10.22, the valuation of TFX can be described as very reasonable.
  • TFX's Price/Forward Earnings ratio is rather cheap when compared to the industry. TFX is cheaper than 94.57% of the companies in the same industry.
  • TFX is valuated cheaply when we compare the Price/Forward Earnings ratio to 25.11, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 9.57
Fwd PE 10.22
TFX Price Earnings VS Forward Price EarningsTFX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, TFX is valued cheaply inside the industry as 88.04% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, TFX is valued cheaper than 87.50% of the companies in the same industry.
Industry RankSector Rank
P/FCF 21.09
EV/EBITDA 11.87
TFX Per share dataTFX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

  • TFX's earnings are expected to decrease with -4.92% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)3.44
EPS Next 2Y0.56%
EPS Next 3Y-4.92%

4

5. TFX Dividend Analysis

5.1 Amount

  • TFX has a Yearly Dividend Yield of 1.14%.
  • Compared to an average industry Dividend Yield of 0.20, TFX pays a better dividend. On top of this TFX pays more dividend than 94.57% of the companies listed in the same industry.
  • TFX's Dividend Yield is slightly below the S&P500 average, which is at 1.82.
Industry RankSector Rank
Dividend Yield 1.14%

5.2 History

  • The dividend of TFX decreases each year by -0.38%.
  • TFX has paid a dividend for at least 10 years, which is a reliable track record.
  • TFX has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)-0.38%
Div Incr Years0
Div Non Decr Years6
TFX Yearly Dividends per shareTFX Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • The earnings of TFX are negative and hence is the payout ratio. TFX will probably not be able to sustain this dividend level.
  • TFX's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP-6.65%
EPS Next 2Y0.56%
EPS Next 3Y-4.92%
TFX Yearly Income VS Free CF VS DividendTFX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M

TFX Fundamentals: All Metrics, Ratios and Statistics

TELEFLEX INC

NYSE:TFX (3/5/2026, 1:42:25 PM)

117.12

-2.06 (-1.73%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-26
Earnings (Next)04-29
Inst Owners108.18%
Inst Owner Change-1.36%
Ins Owners0.3%
Ins Owner Change3.95%
Market Cap5.18B
Revenue(TTM)2.96B
Net Income(TTM)-905.64M
Analysts65.56
Price Target137.93 (17.77%)
Short Float %5.56%
Short Ratio2.52
Dividend
Industry RankSector Rank
Dividend Yield 1.14%
Yearly Dividend1.33
Dividend Growth(5Y)-0.38%
DP-6.65%
Div Incr Years0
Div Non Decr Years6
Ex-Date03-06
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-20.71%
Min EPS beat(2)-48.83%
Max EPS beat(2)7.42%
EPS beat(4)2
Avg EPS beat(4)-8.2%
Min EPS beat(4)-48.83%
Max EPS beat(4)9.84%
EPS beat(8)5
Avg EPS beat(8)-3.27%
EPS beat(12)9
Avg EPS beat(12)-0.42%
EPS beat(16)13
Avg EPS beat(16)0.27%
Revenue beat(2)1
Avg Revenue beat(2)-18.73%
Min Revenue beat(2)-38.72%
Max Revenue beat(2)1.26%
Revenue beat(4)2
Avg Revenue beat(4)-9.51%
Min Revenue beat(4)-38.72%
Max Revenue beat(4)1.26%
Revenue beat(8)3
Avg Revenue beat(8)-5.44%
Revenue beat(12)6
Avg Revenue beat(12)-3.31%
Revenue beat(16)7
Avg Revenue beat(16)-2.86%
PT rev (1m)-2.81%
PT rev (3m)1.23%
EPS NQ rev (1m)-0.48%
EPS NQ rev (3m)-2.11%
EPS NY rev (1m)-0.25%
EPS NY rev (3m)-0.12%
Revenue NQ rev (1m)3.21%
Revenue NQ rev (3m)2.79%
Revenue NY rev (1m)-0.06%
Revenue NY rev (3m)-0.8%
Valuation
Industry RankSector Rank
PE 9.57
Fwd PE 10.22
P/S 1.75
P/FCF 21.09
P/OCF 15.2
P/B 1.66
P/tB N/A
EV/EBITDA 11.87
EPS(TTM)12.24
EY10.45%
EPS(NY)11.46
Fwd EY9.78%
FCF(TTM)5.55
FCFY4.74%
OCF(TTM)7.71
OCFY6.58%
SpS67.05
BVpS70.7
TBVpS-15.94
PEG (NY)N/A
PEG (5Y)3.44
Graham Number139.53
Profitability
Industry RankSector Rank
ROA -13.04%
ROE -28.98%
ROCE 7.39%
ROIC 5.83%
ROICexc 6.21%
ROICexgc 18.25%
OM 15.41%
PM (TTM) N/A
GM 53.3%
FCFM 8.28%
ROA(3y)-2.44%
ROA(5y)1%
ROE(3y)-6.44%
ROE(5y)0.53%
ROIC(3y)3.28%
ROIC(5y)4.67%
ROICexc(3y)3.44%
ROICexc(5y)4.94%
ROICexgc(3y)14.94%
ROICexgc(5y)24.92%
ROCE(3y)4.15%
ROCE(5y)5.91%
ROICexgc growth 3Y-32.67%
ROICexgc growth 5Y-21.74%
ROICexc growth 3Y-19.62%
ROICexc growth 5Y-11.23%
OM growth 3Y-11.31%
OM growth 5Y-8.15%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.83%
GM growth 5Y1.5%
F-Score4
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 0.81
Debt/FCF 10.76
Debt/EBITDA 4.01
Cap/Depr 53.58%
Cap/Sales 3.21%
Interest Coverage 3.83
Cash Conversion 53.69%
Profit Quality N/A
Current Ratio 2.54
Quick Ratio 2.01
Altman-Z 2.31
F-Score4
WACC9.62%
ROIC/WACC0.61
Cap/Depr(3y)46.97%
Cap/Depr(5y)41.09%
Cap/Sales(3y)4.27%
Cap/Sales(5y)3.64%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-12.63%
EPS 3Y-2.14%
EPS 5Y2.78%
EPS Q2Q%-50.39%
EPS Next Y-6.4%
EPS Next 2Y0.56%
EPS Next 3Y-4.92%
EPS Next 5Y-1.79%
Revenue 1Y (TTM)-2.75%
Revenue growth 3Y-10.62%
Revenue growth 5Y-4.72%
Sales Q2Q%-28.47%
Revenue Next Year-12.37%
Revenue Next 2Y-4.6%
Revenue Next 3Y-8.6%
Revenue Next 5Y-3.02%
EBIT growth 1Y-16.3%
EBIT growth 3Y-20.73%
EBIT growth 5Y-12.48%
EBIT Next Year-18.47%
EBIT Next 3Y-6.15%
EBIT Next 5Y7.42%
FCF growth 1Y-54.99%
FCF growth 3Y-2.27%
FCF growth 5Y-6.62%
OCF growth 1Y-46.41%
OCF growth 3Y-0.14%
OCF growth 5Y-4.83%

TELEFLEX INC / TFX FAQ

What is the ChartMill fundamental rating of TELEFLEX INC (TFX) stock?

ChartMill assigns a fundamental rating of 4 / 10 to TFX.


What is the valuation status for TFX stock?

ChartMill assigns a valuation rating of 7 / 10 to TELEFLEX INC (TFX). This can be considered as Undervalued.


What is the profitability of TFX stock?

TELEFLEX INC (TFX) has a profitability rating of 5 / 10.


What is the valuation of TELEFLEX INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for TELEFLEX INC (TFX) is 9.57 and the Price/Book (PB) ratio is 1.66.


How financially healthy is TELEFLEX INC?

The financial health rating of TELEFLEX INC (TFX) is 5 / 10.